Chan Ho Kim Selected Research

Chan Ho Kim Research Topics

Disease

11	Neoplasms (Cancer) 12/2023 - 12/2014
6	Chronic Kidney Failure (Chronic Renal Failure) 05/2019 - 09/2009
3	Acute Kidney Injury (Acute Renal Failure) 12/2014 - 08/2013
3	Inflammation (Inflammations) 10/2013 - 12/2012
2	Chronic Renal Insufficiency 01/2023 - 06/2013
2	Diabetes Mellitus 08/2015 - 01/2014
2	Septic Shock (Toxic Shock Syndrome) 01/2015 - 12/2013
2	Sepsis (Septicemia) 01/2015 - 12/2013
1	Obesity 05/2023
1	Anemia 01/2023
1	Colitis 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Ureteral Obstruction 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Gout 04/2020
1	Arteriovenous Fistula 05/2019
1	Hypertrophy 08/2015
1	Critical Illness (Critically Ill) 08/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Weight Gain 01/2014
1	Infections 12/2013
1	Malnutrition (Nutritional Deficiencies) 10/2013
1	Hypothyroidism 06/2013
1	Dyslipidemias (Dyslipidemia) 06/2013
1	Proteinuria 06/2013
1	Kidney Diseases (Kidney Disease) 06/2013
1	Insulin Resistance 12/2012
1	Hyperpigmentation 09/2009
1	Erythema 09/2009

Drug/Important Bio-Agent (IBA)

5	C-Reactive ProteinIBA 12/2014 - 12/2012
3	AlbuminsIBA 12/2014 - 12/2013
2	Cancer VaccinesIBA 12/2023 - 01/2022
2	AntigensIBA 12/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
2	CreatinineIBA 04/2020 - 06/2013
1	VaccinesIBA 12/2023
1	TunicamycinIBA 12/2023
1	Resistant StarchIBA 05/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	Receptor for Advanced Glycation End ProductsIBA 01/2023
1	AntibodiesIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	LigandsIBA 01/2023
1	PolymersIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	SulfonamidesIBA 01/2022
1	Sulfisoxazole (Sulfafurazole)FDA Link 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	quinone methideIBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2021
1	Endothelin Receptor AntagonistsIBA 01/2021
1	macitentanIBA 01/2021
1	titanium dioxide (Titania)FDA Link 10/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2020
1	Uric Acid (Urate)IBA 04/2020
1	Uricosuric AgentsIBA 04/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2019
1	Peptide Elongation Factors (Elongation Factor)IBA 08/2015
1	Ribosomal Proteins (Ribosomal Protein)IBA 08/2015
1	ErbB Receptors (EGF Receptor)IBA 08/2015
1	Streptozocin (Streptozotocin)FDA Link 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	CaspasesIBA 08/2015
1	PKI 166IBA 08/2015
1	benzyloxycarbonyl- Asp- CH2OC(O)- 2,6- dichlorobenzeneIBA 08/2015
1	Phosphotransferases (Kinase)IBA 08/2015
1	8-epi-prostaglandin F2alphaIBA 01/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014
1	LDL CholesterolIBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2013
1	Hemoglobins (Hemoglobin)IBA 12/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2013
1	Insulin-Like PeptidesIBA 10/2013
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2013
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	Parathyroid Hormone (Parathormone)IBA 06/2013
1	Thyroid HormonesIBA 06/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2012
1	Melanins (Melanin)IBA 09/2009

Therapy/Procedure

8	Therapeutics 01/2023 - 09/2009
3	Immunotherapy 01/2023 - 01/2022
3	Renal Dialysis (Hemodialysis) 05/2019 - 10/2013
3	Continuous Renal Replacement Therapy 12/2014 - 08/2013
2	Photochemotherapy (Photodynamic Therapy) 10/2020 - 01/2020
2	Early Goal-Directed Therapy 01/2015 - 12/2013
2	Resuscitation 01/2015 - 12/2013
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2013 - 06/2013
2	Peritoneal Dialysis 10/2013 - 12/2012
1	Length of Stay 12/2013